Download PDF
June 22, 2018

Brian Xu, M.D., Ph.D., DABT®, Quoted in Nature Article “US–Chinese Trade War Puts Scientists In The Cross Hairs”

The ACTA Group

On June 22, 2018, Brian Xu, M.D., Ph.D., DABT®, Toxicologist with The Acta Group (Acta®), was quoted by Nature regarding proposed Chinese tariffs on U.S. chemicals and scientific equipment.

Brian Xu, a toxicologist for the scientific consulting firm ACTA in Washington DC, which works with businesses in mainland China, agrees that China’s proposal to place tariffs on US chemicals and scientific equipment is unlikely to have a major effect on Chinese research. He notes that scientists there import only a small amount of US-made chemicals, and that infrequently-replaced scientific equipment from other countries, such as Japan and Germany, is of comparable quality and cost.

See –